1. Stoykova Z, Ivanova L, Ikonomov V, Teodorova I, Todorova T. Monitoring of CMV infection
in kidney transplant recipients. J of IMAB. 2017; 23(4):1834-1838.
2. De Keyzer K, Van Laecke S, Peeters P, Vanholder R. Human Cytomegalovirus and Kidney Transplantation: A Clinician's Update. AJKD. 2011; 58 (1):118-26.
3. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. 7th ed. Philadelphia: Saunders, Elsevier, 2013, ch 51, pp: 477-481.
4. Greenwood D, Barer M, Slack R, Irving W. Herpesviruses: In Medical Microbiology
.A Guide to Microbial infection. 18th ed. Edinburgh: Churchill Livingstone Elsevier, 2011, ch 43.pp: 437-441.
5. Azevedo LS, Pierrotti LC, Abdala E, Costa SF, Strabelli TM, Campos SV, et al. Cytomegalovirus
infection in transplant recipients. Clinics (Sao Paulo, Brazil).2015; 70(7): 515-23.
6.Cukuranovic J, Ugrenovic S, Jovanovic I, Visnjic M, Stefanovic V. Viral Infection
in Renal Transplant Recipients. Scientific World J. 2012; 2012: 1-18.
7. Kotton, CN, Fishman. JA. Viral infection in the renal transplant recipient. J Am Soc Nephrol. 2005; 16(6): 1758-1774.
8. McBride, JM. Sheinson D, Jiang J, Lewin-Koh N, Werner BG, Chow JK, et al. Correlation
of cytomegalovirus (CMV) disease severity and mortality with CMV viral burden in CMV-seropositive
donor and CMV-seronegative solid organ transplant recipients. Open Forum Infectious
Diseases. Vol. 6. No. 2. US: Oxford University Press, 2019; p, ofz003.
9. Ciotti M, Cella E, Rittà M, Ciccozzi M, Cavallo R, Perno CF, et al. Cytomegalovirus
Glycoprotein B Genotype Distribution in Italian Transplant Patients. Intervirology.
2017; 60(4): 165-170.
10. Jun F, Minhuan L, Yadan M, Yaping H, Hanying L, Jianhua H, et al . Development
of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein
B. Braz. J. Med. Biol. Res. 2012; 45(7) 2012: 583-590.
11. Halling VW, Maine GT, Groettum CM, Wilson JA, Spesard J, Brojanac S, Wang D. Clinical
evaluation of a new recombinant antigen-based cytomegalovirus immunoglobulin M immunoassay
in liver transplant recipients. TRANSPLANTATION. 2001; 71(3): 395-397.
12. Deckers M, Hofmann J, Kreuzer K, Reinhard H, Edubio A, Hengel H, et al. High genotypic
diversity and a novel variant of human cytomegalovirus revealed by combined UL33/UL55
genotyping with broad-range PCR. Virol. J. 2009; 6:210-221.
13. Gandhoke I, Hussain SA, Pasha ST, Chauhan LS, Khare S. (2013). Glycoprotein B
Genotyping in Congenital/perinatal Cytomegalovirus Infection in Symptomatic Infants.
Indian Pediatr. 2013; 50(7):663-667.
14. Atschul SF, Madden TL & Schaffer AA. Gapped BLAST and PSI-BLAST. A new generation
of protein database search programmes. Nucleic Acid Res.1997; 25 (17): 3389-3402.
15. Hall, TA. BioEdit: a user-friendly biological sequence alignment editor and analysis
program for Windows 95/98/NT. Nucl.Acids.Symp.Ser. [London]: Information Retrieval Ltd., c1979-c2000., 1999; 41(41):95-98.
16. Capriotti E, Fariselli P, Rossi I, Casadio R. A three state prediction of single
point mutations on protein stability change. BMC Bioinformatics. (2008); 9(2):S6
17. Huang CC, Meng EC, Morris JH. Enhancing UCSF Chimera through web. Nucleic Acids
Res.2014; 42(Web Server issue): W478-484.
18. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary
Genetics Analysis Version 6.0. Molecular Bio and Evol.2013; 30 (12): 2725-2729.
19. Hasanzamani B, Hami B, Zolfaghari V, Torkamani M, Sabagh MG, Simab AS. The effect
of cytomegalovirus infection on acute rejection in kidney transplanted patients. J
Renal Inj Prev. 2016; 5(2): 85-88.
20. Khameneh ZR, Sepehrv, Aghazadeh T. Cytomegalovirus Infection among Iranian Kidney
Graft Recipients. Transplant Proc.2013; 45(1):178-181.
21. Nafar M, Roshan A, Pour-Reza-Gholi F, Samadian F, Ahmadpoor P, Samavat S, et al. Prevalence
and Risk Factors of Recurrent Cytomegalovirus Infection in Kidney Transplant Recipients. Iran J Kidney Dis. 2014; 8(3): 231-235.
22.
Al-Alousy BM,
Abdul-Razak SH,
Al-Ajeeli>, KS,
Al-Jashamy KA. Anti-HCMV IgG positivity rate among renal transplant recipients in Baghdad. Saudi Kidney Dis Transplant. 2011; 22(6): 1269-1274.
23. Tong CW, Cuevas LE, Williams H, Bakran A. Prediction and Diagnosis of Cytomegalovirus Disease in Renal Transplant Recipients
Using Qualitative and Quantitative Polymerase Chain Reaction. TRANSPLANT. 2000; 69(5): 985-991
24. Madi A, Al-Nakib W, Mustafa A, Saeed T, Pacsa A, Nampoory MN. Detection and Monitoring
of Cytomegalovirus Infection in Renal Transplant Patients by Quantitative Real-Time
PCR. Med Princ Pract. (2007); 16(4):268-273.
25. Enan KA, El-Hussein AM, El Eragi A, Elkhider IM. Sero-reactivity to human cytomegalovirus
in a cohort of Sudanese renal transplant patients. Khartoum Medical J.2009; 2(2): 197-199.
26. Lashini H, Goodarzi Z, Hosseini MJ, Saberfar E. Development of PCR assay for early
detection of CMV infection in renal transplant recipients. Nephro-Urol Mon.2011; 3(2):106-108.
27. Garrigue I, Doussau A, Asselineau J, Bricout H, Couzi L, Rio C, et al. Prediction of Cytomegalovirus (CMV) Plasma Load from Evaluation of CMV Whole-Blood
Load in Samples from Renal Transplant Recipients. J.Clin. Microbiol.2008; 46(2): 493-498.
28. Zhang CB, Lai HY, Xu HT, Wang DG, Xiao F. Clinical application of real time-polymerase chain reaction in determining cytomegalovirus
viral DNA load in renal transplant recipients.
Chin Med J (Engl). 2012; 125(19):3575-3577.
29. Cordero E,
Casasola C,
Ecarma R,
Danguilan R. Cytomegalovirus disease in kidney transplant recipients: incidence, clinical profile,
and risk factor. Transplant Proc. 2012; 44(3):694-700.
30. Cupic M, Lazarevic J, Pravica V, Banko A, Karalic D, Naumovic R, et al. The prevalence
of the most important viral infection in renal transplant recipients in Serbia. Arch.
Biol. Sci. 2012; 64(4): 1285-1296.
31. Khalafkhany D, Makhdoomi K, Afshari AT. Prevalence and genotype distribution of cytomegalovirus UL55 sequence in renal transplant
recipients in North West of Iran. J Med Virol
. (2016); 88(9):1622-1627.
32. Hadaya K, Wunderli W, Deffernez C, Martin PY, Mentha G, Binet I, et al. Monitoring
of Cytomegalovirus infection in solid- organ transplant recipients by an ultrasensitive
plasma PCR assay. J Clin Micorbiol. 2003; 41(8):3757-3764.
33. Knipe DM, Howley PM. Cytomegaloviruses. Fields Virology. 5th ed. vol 2. Philadelphia: Lippincott, Williams and Wilkins, 2007, ch 21, pp: 2703-2705.
34. Helanterä I, Kyllönen L, Lautenschlager I, Salmela K, Koskinen P. Primary CMV
Infections are Common in Kidney Transplant Recipients after 6 Months Valganciclovir
Prophylaxis. Am. J. Transplant. 2010; 10(9): 2026-2032.
35. Rangbar-Kermani R, Sharifi Z, Mahmoodian-Shooshtari M, Mousavi K. Quantitative
Analysis of CMV-DNA Load in Renal Transplant Recipients Using Real-Time PCR. Iran J Virol. 2011; 5(1): 31-33.
36. ArdalanM. Rare Presentations of Cytomegalovirus Infection in Renal Allograft Recipients.
Nephro-Urol Mon. (2012); 4(2):431-436.
37. Arista, A, De Grazia, A, Giammanco, GM, Di Carlo P, Iannitto E. Human cytomegalovirus
glycoprotein B genotypes in immunocompetent, immunocompromised, and congenitally infected
Italian populations. Arch Virol.2003; 148(3): 547-554.
38. De Vries JJ, Korver AM, Verkerk PH, Rusman L, Claas EC, Loeber JG, et al. Congenital Cytomegalovirus Infection in the Netherlands: Birth Prevalence and
Risk Factors. J Med Virol. 2011; 83(10):1777-1782.
39. Pacsa AS, Essa S, Voevodin, A, El-Shazly A, Kazak H, Nampoory MRN, et al. Correlation
between CMV genotypes, multiple infections with herpesviruses (HHV-6, 7) and development
of CMV disease in kidney recipients in Kuwait. FEMS IMMUNOL MEDMIC.2003; 35(2):125-130.
40. Coaquette A, Bourgeois A, Dirand C, Varin A, Chen W, Herbein G. (2004). Mixed Cytomegalovirus Glycoprotein
B Genotypes in Immunocompromised Patients. Clin Infect Dis. 2004; 39(2):155-161.
41. Dieamant DD, Bonon SHA, Prates LC, Belangelo VMS, Pontes ER, Costa SCB. Active
human Cytomegalovirus infection and Glycoprotein B genotypes in Brazilian pediatric
renal or hematopoietic stem cell transplantation patient. Braz J Microbiol.2010; 41(1): 262-274. ISSN: 1678-4405.
42. Renzette N, Gibson L, Jensenand JD, Kowalik TF. Human cytomegalovirus intrahost
evolution - a new avenue for understanding and controlling herpesvirus infections.
Curr Opin in Virol. 2014; 8:109-115.
43. Jun F, Minhuan L, Yadan M, Yaping H, Hanying L, Jianhua H, et al. Development
of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein
B. Braz. J. Med. Biol. Res. 2012; 45(7): 583-590.
44. Stangherlin LM, DePoula FN, Icimoto MY, Ruuiz LGP, Noqueita ML, Braz, ASK, et
al. Positively selected sites at HCMV gBFurin processing region their effects in cleavage
efficiency. ForntMicrobiol. 2017; 8:934.